Leslie Citrome, MD, MPH

Adjunct Professor of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

JCP
Original Research

December 15, 2020

Transdermal asenapine administration may address unmet needs in patients with schizophrenia, including improved adherence. This phase 3 study assessed efficacy and safety of HP-3070, an asenapine transdermal system (patch),...
, , , et al
JCP
Consensus Statement

May 19, 2020

The quantification of antipsychotic levels in blood, or therapeutic drug monitoring (TDM), could aid clinicians in numerous challenging scenarios. Learn more about using TDM for dosing decisions in this...
, , , et al
JCP
Original Research

March 10, 2020

Alcohol use disorder is comorbid in 33% of US patients with schizophrenia. Testing the tolerability of olanzapine and samidorphan until the first event of exacerbation of disease symptoms is...
, , , et al
JCP
Consensus Statement

January 28, 2020

Tardive dyskinesia remains a serious complication associated with dopamine receptor blocking agents. In this article, read guidance from experts on best practices for tardive dyskinesia screening, diagnosis, and treatment.
, , , et al
JCP
ASCP Corner

December 4, 2019

Are electronic prescribing alerts useful or simply annoying? A survey gathered the opinions of ASCP members on several aspects of these alerts, including how often they are inaccurate and...
,
JCP
Educational Activity

July 30, 2019

New mechanisms of action present new opportunities to improve outcomes for patients with depression. Listen to a panel of experts discuss best practices and novel antidepressants at the 2019...
, , , et al
JCP
Review Article

July 16, 2019

Transdermal delivery is an alternative to oral routes of drug administration. This delivery route has several innate advantages that may benefit patients with CNS disorders—read this Expert Commentary to...
, ,
JCP
Letter to the Editor

October 25, 2017

, , , et al
JCP
Letter to the Editor

May 24, 2017

,
JCP
Supplement Article

January 25, 2017

JCP
Original Research

December 28, 2016

What's the next step when a patient doesn' t respond to an antipsychotic? Should you augment, switch medications, wait and see, or raise the dose? Read this study in...
, , , et al
JCP
Supplement Article

September 30, 2016

Read the recommendations of experts on the use of long-acting injectable antipsychotic medications in patients with schizophrenia.
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe